GLACTONE PHARMA DEVELOPMENT AB
5Patents
5Active
5Granted
43Portfolio score
Filing activity: Jul 18, 2011 → Aug 9, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10538500B2 | Tricyclic prodrugs | Chemistry; Metallurgy | 0 | Active |
| US10077246B2 | Tricyclic prodrugs | Chemistry; Metallurgy | 0 | Active |
| US10781197B2 | Sulfonamide analogues of galiellalactone | Chemistry; Metallurgy | 0 | Active |
| US9150531B2 | Tricyclic lactones for treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US10351577B2 | Ether analogues of galiellalactone | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.